MichaelGirardiMD
Dermatology • New Haven, CTProfessor, Dermatology, Yale University School of Medicine
Dr. Girardi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
15 York St
2 Church St South, Suite 305
New Haven, CT 06510Phone+1 203-789-1249Fax+1 203-785-3315- Is this information wrong?
Education & Training
Yale-New Haven Medical CenterResidency, Dermatology, 1994 - 1997- Yale-New Haven Medical CenterInternship, Internal Medicine, 1992 - 1993
Yale School of MedicineClass of 1992
Brown UniversityBS & BA, Biology & Computer Science, Magna Cum Laude, 1984 - 1988
Certifications & Licensure
CT State Medical License 1997 - 2025- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 2008
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- A Sunscreen Based on Bioadhesive Nanoparticles Start of enrollment: 2017 Jul 17
- A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL) Start of enrollment: 2020 Jan 15
Publications & Presentations
PubMed
- Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy.Ren, J., Liao, X., Lewis, J., Chang, J., Qu, R., Carlson, K., Foss, F., Girardi, M.> ;Nature Communications. 2024 Jan 15
- FISH Panel for Leukemic Cutaneous T-Cell Lymphoma: Extended Patient Cohort Correlation with Blood Involvement and Clinical Outcomes.Jonathan Avery, Sa Rang Kim, Wei Cheng, Francine Foss, Michael Girardi> ;JID Innovations. 2023 Sep 1
- 4 citationsNanoparticles as a Therapeutic Delivery System for Skin Cancer Prevention and Treatment.Jungsoo Chang, Beverly Yu, W Mark Saltzman, Michael Girardi> ;JID Innovations. 2023 Jul 1
- Join now to see all
Journal Articles
- Clarification Regarding Noninferiority and a Discussion of Model Selection and Treatment Effects in Observational Research—ReplyMichael Girardi, MD, JAMA Dermatology
- Evaluation of Lymph Node Ratio Association with Long-Term Patient Survival After Surgery for Node-Positive Merkel Cell CarcinomaMichael Girardi, Shayan Cheraghlou, JAMA
Authored Content
- Clarification Regarding Noninferiority and a Discussion of Model Selection and Treatment Effects in Observational Research—ReplyJune 2020
Press Mentions
2023 ‘Top Doctors’ List Features Over 250 Yale Medicine PhysiciansMay 3rd, 2023- Connecticut Magazine’s 2023 “Top Doctors” Issue Recognizes 82 Smilow Cancer Hospital and Yale Cancer Center PhysiciansMay 1st, 2023
- For the Best Melanoma Prognosis, Location MattersApril 2nd, 2021
- Join now to see all
Grant Support
- Local Immunoregulation Of CarcinogenesisNational Cancer Institute2010–2011
- T Cell Regulation Of Cutaneous MalignancyNational Cancer Institute2003–2007
- TCR DNA Immunization For 2b411 T Cell LymphomaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–2002
Professional Memberships
- Fellow
Hospital Affiliations
Yale-New Haven HospitalNew Haven, Connecticut
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
